Hepatitis B vaccineThe hepatitis B virus is the most common cause world-wide of acute hepatitis, and also causes chronic hepatitis, cirrhosis1 and primary liver cancer.2 It can now be prevented by a vaccine. How should this best be used?BMJDrug & Therapeutics Bulletin...
HBV causes acute and chronic hepatitis B; chronic HBV infection puts more than 250 million virus carriers at a greatly increased risk to develop terminal liver disease, i.e., liver fibrosis, cirrhosis and hepatocellular carcinoma (HCC) [1]. While an effective prophylact...
intramuscular, subcutaneous, transdermal, or sublingual administration. The method can further involve administering to the subject a vaccine comprising the hepatitis B surface antigen (HBsAg).
To make measuring units easier, connection which is wireless has been configured between smartphone and potentiostat called NFC interface that makes the potentiostat into passive operated device running without battery. Using amperometric detection, the hepatitis B antigen (HBsAg) was qualified with the ...
A smartphone-controlled electrochemical sensor operated entirely via Near Field Communication (NFC) was used to create a simple label-free immunoassay for detecting Hepatitis B Virus (HBV). The completed system was composed of a card-sized electrochemical NFC tag sensor integrated with a smartphone ...
Closing in on hepatitis B.Reports that the drug lamivudine, that was developed in Canada, is shaping up as a potent treatment for hepatitis B. The results of a clinical trial reported; Development of the drug by BioChem Pharma; Licensing belonging to Glaxo-Wellcome.EBSCO_Asp...
Methods 307 HBeAg-positive patients with chronic hepatitis B were assigned combination therapy (100 g/week pegylated interferon alfa-2b and 100 mg/day lamivudine) or monotherapy (100 g/week pegylated interferon alfa-2b and placebo) for 52 weeks. During weeks 32 --52 the pegylated interferon ...
Hepatitis C mortality trends in San Francisco: can we reach elimination targets? - ScienceDirectAli Mirzazadeh MD, MPH, PhD a bShelley N. Facente MPH, PhD c fKatie Burk MPH dJames G. Kahn MD, MPH eMeghan D. Morris PhD, MPH a b f...
hepatitis CimmunosuppressantpsoriasisreactivationThe increasing use of biologics is accompanied by a risk of hepatitis B (HBV) and C virus (HCV) reactivation.To determine the predictors of HBV and HCV reactivation in psoriasis patients receiving biologics.This study screened 2060 psoriasis patients (3562...
Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)/HBeAg (-) mothers. Vaccine 2017, 35, 40–45. [CrossRef] [PubMed] 35. Pan, C.Q.; Duan, Z.; Dai, E.; Zhang, S.; Han, G.; Wang, Y.; Zhang, H.; Zou, H.; Zhu...